Ocugen
Price & Volume
Stats
See moreOpen | $1.72 |
Previous Close | $1.73 |
Day Range | $1.72-$1.79 |
52W Range | $0.64-$2.72 |
Market Cap | $568.7M |
Shares Short | 67M |
Financials
See moreRevenue (12 Mos) | $4.4M |
Revenue Growth (YoY) | 54.2% |
Gross Profit (12 Mos) | -$35.3M |
Diluted EPS | -$0.23 |
News
See moreYahoo Finance • 3 days ago
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
Yahoo Finance • last month
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Yahoo Finance • last month
Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy
Yahoo Finance • 2 months ago
Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat
About
CEO | Dr. Shankar Musunuri M.B.A., Ph.D. |
Address | 11 Great Valley Parkway, Malvern, PA, United States, 19355 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 116 |